BioSpace News Archive

Business

J&J Earns $13.2B from Kenvue Spinout, Lowers Guidance

Johnson & Johnson on Wednesday reported multi-billion earnings from its Kenvue consumer health spinout, with updated 2023 revenue guidance down from its previously announced range.

August 31, 2023
·
2 min read
·
Tristan Manalac
FDA

FDA Approves Generics of Takeda’s ADHD, Binge Eating Drug Vyvanse

Amid a supply shortage of the attention-deficit/hyperactivity disorder and binge-eating disorder medication, the regulator has cleared a slew of generic drugs of Takeda’s Vyvanse pill.

August 31, 2023
·
2 min read
·
Tristan Manalac
Business

Sage Cuts Staff by 40% After FDA’s MDD Rejection

Following the FDA’s recent rejection of zuranolone in major depressive disorder, Sage Therapeutics has launched a strategic reorganization initiative including a 40% reduction in headcount.

August 31, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Coveted GLP-1 Drugs Show Early Promise in Alzheimer’s Disease

With a recent study yielding positive results, experts say GLP-1 drugs are making headway in treating Alzheimer’s and other neurodegenerative diseases.

August 31, 2023
·
5 min read
·
Heather McKenzie
Policy

Alkermes Settles Patent Lawsuit with Teva Over Generic Vivitrol

The settlement, announced Wednesday, ends a three-year legal battle allowing Teva Pharmaceuticals to make a generic version of Alkermes’ alcohol and opioid dependence drug Vivitrol.

August 31, 2023
·
2 min read
·
Connor Lynch
Business

Press Release: Sanofi announces changes to its Executive Committee

Houman, Madeleine and Emmanuel will report to Sanofi’s CEO, Paul Hudson, and will be based in Paris, France.

August 31, 2023
·
11 min read
Pharm Country

Inventiva announces a financing of approximately €35.7 million from new and existing investors, consisting of a €30.6 million reserved capital increase and a €5.1 million issuance of royalty certificates

Inventiva, a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis and other diseases with significant unmet medical needs, announced an approximately €35.7 million financing.

August 31, 2023
·
23 min read
Business

Burning Rock Reports Second Quarter 2023 Financial Results

Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, reported financial results for the three months ended June 30, 2023.

August 31, 2023
·
19 min read
Business

Christina Ackermann Joins Verona Pharma as Non-Executive Director

Verona Pharma plc, announces effective September 1, 2023, Ms. Christina Ackermann will join the board as a Non-Executive Director.

August 31, 2023
·
3 min read
Business

Syngenta Group Reports H1 2023 Results

Syngenta Group announced financial results for the first half and the second quarter of 2023.

August 31, 2023
·
10 min read